Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bassel Akache

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Frontiers in Immunology|May 1, 2023
Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concernTyler M Renner, Bassel Akache, Matthew Stuible, et al.
NPJ Vaccines|October 12, 2022
Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concernBassel Akache, Tyler M Renner, Matthew Stuible, et al.
Vaccine|October 31, 2024
SARS-CoV-2 spike-based virus-like particles incorporate influenza H1/N1 antigens and induce dual immunity in miceZalma V Sanchez-Martinez, Sergio P Alpuche-Lazcano, Matthew Stuible, et al.
Vaccines|June 28, 2023
Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and EfficaciousBassel Akache, Andrew J Read, Renu Dudani, et al.
Scientific Reports|November 9, 2021
Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvantBassel Akache, Tyler M Renner, Anh Tran, et al.
Scientific Reports|June 13, 2022
Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamstersFelicity C Stark, Bassel Akache, Lise Deschatelets, et al.
Communications Medicine|August 23, 2023
Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cellsSergio P Alpuche-Lazcano, Matthew Stuible, Bassel Akache, et al.
Communications Medicine|April 11, 2025
Modifying the glycosylation profile of SARS-CoV-2 spike-based subunit vaccines alters focusing of the humoral immune response in a mouse modelTyler M Renner, Matthew Stuible, Martin A Rossotti, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Frontiers in Immunology|May 1, 2023
Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concernTyler M Renner, Bassel Akache, Matthew Stuible, et al.
NPJ Vaccines|October 12, 2022
Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concernBassel Akache, Tyler M Renner, Matthew Stuible, et al.
Vaccine|October 31, 2024
SARS-CoV-2 spike-based virus-like particles incorporate influenza H1/N1 antigens and induce dual immunity in miceZalma V Sanchez-Martinez, Sergio P Alpuche-Lazcano, Matthew Stuible, et al.
Vaccines|June 28, 2023
Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and EfficaciousBassel Akache, Andrew J Read, Renu Dudani, et al.
Scientific Reports|November 9, 2021
Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvantBassel Akache, Tyler M Renner, Anh Tran, et al.
Scientific Reports|June 13, 2022
Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamstersFelicity C Stark, Bassel Akache, Lise Deschatelets, et al.
Communications Medicine|August 23, 2023
Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cellsSergio P Alpuche-Lazcano, Matthew Stuible, Bassel Akache, et al.
Communications Medicine|April 11, 2025
Modifying the glycosylation profile of SARS-CoV-2 spike-based subunit vaccines alters focusing of the humoral immune response in a mouse modelTyler M Renner, Matthew Stuible, Martin A Rossotti, et al.
Pageof 5